セリアック病(Celiac Disease):治療薬開発パイプライン動向2014

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DELVE41017115)
◆英語タイトル:Celiac Disease-Pipeline Insights, 2014
◆発行会社/調査会社:DelveInsight
◆商品コード:DELVE41017115
◆発行日:2014年版(※最新版はお問い合わせください)
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:60以上
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(納品まで約3営業日)
◆販売価格オプション(消費税別)
Single User(1名使用)USD1,250 ⇒換算¥136,250見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD2,500 ⇒換算¥272,500見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD4,000 ⇒換算¥436,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[セリアック病(Celiac Disease):治療薬開発パイプライン動向2014]についてメールでお問い合わせはこちら
本調査レポートでは、世界におけるセリアック病(Celiac Disease)の治療薬開発パイプライン動向について調査・分析し、企業別開発中の治療薬、各臨床試験段階における製品リスト及び比較分析、薬剤候補のプロファイル、治療薬の評価、開発中止又は開発休止中の製品リスト等をお届けしています。また、セリアック病(Celiac Disease)治療薬開発に取り組んでいる企業情報も提供しています。(※本レポートはご注文を頂いてから、最新データに更新して納品しているため、正確なページ数を明記しておりません。)

・セリアック病(Celiac Disease)の概要

・セリアック病(Celiac Disease)のパイプライン製品概要

・企業別開発中の治療薬

・後期治験段階の製品(Filed & Phase III):比較分析

・中期治験段階の製品(Phase II):比較分析

・初期治験段階の製品(Phase I & IND):比較分析

・前臨床段階の製品:比較分析

・薬剤候補のプロファイル

・セリアック病(Celiac Disease)治療薬の評価
  - 単剤治療薬
  - 併用治療薬
  - 投与経路別
  - 分子の種類別

・開発が中止された製品リスト

・開発休止中の製品リスト

・セリアック病(Celiac Disease)治療薬開発に取り組んでいる企業リスト

・図表一覧
*** レポート概要(サマリー)***

SUMMARY
DelveInsight’s,“ Celiac Disease-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Celiac Disease. This report provides information on the therapeutic development based on the Celiac Disease dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.

[Data Sources]

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated Indication.


Scope
• The report provides a snapshot of the global therapeutic landscape of Celiac Disease
• The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Coverage of the Celiac Disease pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for Celiac Disease and also provide company profiling
• The report also gives the information of dormant and discontinued pipeline projects
• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type


Reasons to buy
• Complete Pipeline intelligence and complete understanding over therapeutics development for Celiac Disease
• Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
• Devise corrective measures for pipeline projects by understanding Celiac Disease pipeline depth and focus of Indication therapeutics
• Developing strategic initiatives to support your drug development activities.
• Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business.
• Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
• Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
• Gaining a Full Picture of the Competitive Landscape for Evidence based Decisions


*** レポート目次(コンテンツ)***

Table of Contents
• Celiac Disease Overview
• Celiac Disease Pipeline Therapeutics
• Celiac Disease Therapeutics under Development by Companies
• Celiac Disease Late Stage Products (Filed and Phase III)
– Comparative Analysis
• Celiac Disease Mid Clinical Stage Products (Phase II)
– Comparative Analysis
• Celiac Disease Early Clinical Stage Products (Phase I and IND Filed)
– Comparative Analysis
• Celiac Disease Discovery and Pre-Clinical Stage Products
– Comparative Analysis
• Drug Candidate Profiles
• Celiac Disease – Therapeutics Assessment
– Assessment by Monotherapy Products
– Assessment by Combination Products
– Assessment by Route of Administration
– Assessment by Molecule Type
• Celiac Disease – Discontinued Products
• Celiac Disease – Dormant Products
• Companies Involved in Therapeutics Development for Celiac Disease
• Appendix
• Methodology
• Contact Us
• Disclaimer

List of Tables
• Number of Products under Development for Celiac Disease, 2014
• Number of Products under Development by Companies
• Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2014
• Comparative Analysis Mid Clinical Stage Products (Phase II), 2014
• Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2014
• Comparative Analysis Discovery and Pre-Clinical Stage Products, 2014
• Drug Candidates Profiles
• Celiac Disease Assessment by Monotherapy Products
• Celiac Disease Assessment by Combination Products
• Celiac Disease Assessment by Route of Administration
• Celiac Disease Assessment by Stage and Route of Administration
• Celiac Disease Assessment by Molecule Type
• Celiac Disease Assessment by Stage and Molecule Type
• Celiac Disease Therapeutics – Discontinued Products
• Celiac Disease Therapeutics – Dormant Products
• Products under Development by Companies, 2014


List of Figures
• Number of Products under Development for Celiac Disease, 2014
• Late Clinical Stage Products (Filed and Phase III), 2014
• Mid Clinical Stage Products (Phase II), 2014
• Early Clinical Stage Products (Phase I and IND Filed), 2014
• Discovery and Pre-Clinical Stage Products, 2014
• Celiac Disease Assessment by Monotherapy Products
• Celiac Disease Assessment by Combination Products
• Celiac Disease Assessment by Route of Administration
• Celiac Disease Assessment by Stage and Route of Administration
• Celiac Disease Assessment by Molecule Type
• Celiac Disease Assessment by Stage and Molecule Type


*** レポートのキーワード ***

セリアック病(Celiac Disease)、治療薬(医薬品、薬剤)、製薬企業、研究開発、治験、製品パイプライン

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • Ply Gem Holdings, Inc.:企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Ply Gem Holdings, Inc." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. World Market Intelli …
  • モジュラーUSPシステムの世界市場
    In this report, the global Modular UPS System market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Milli …
  • ダイズ(Soy)製品市場の展望(~2017):タイ(市場規模、流通・ブランドシェア、主要イベント、競争環境)
    ※当レポートはタイのダイズ(Soy)製品の消費トレンド、市場規模(過去、予測)、ブランドシェア、販売チャネル、関連企業プロフィール、業界のM&A動向を含む最新ニュースなどをまとめました。 ■Product Synopsis "The Future of the Soy Products Market in Thailand to 2017: Market Size, Distribution and Brand Share, Key Events and Competitive Landscape" is the result of Canadean's extensive market an …
  • (株) デジン電池(DAEJIN BATTERY:製造業)の企業概要・財務データ:韓国企業調査
    韓国企業の概要及び財務データをまとめたレポートです。該当企業の設立日、住所、社員数、資本金、事業分野、連絡先、企業格付などの概要と、最近3年間の会計年度別貸借対照表(B/S)、損益計算書(P/L)、キャッシュ・フロー計算書(C/F)など財務データを調査しました。 韓国企業と取引する時、韓国に進出を検討する時、或いは韓国の競合企業を調べる時に、本データをご活用ください。追加のデータや詳しい情報が必要な場合は別途カスタムリサーチ(委託調査)サービスで対応致します。
  • 世界及び中国のアゾカルミンB市場2016
    The 'Global and Chinese Azocarmine B Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Azocarmine B industry with a focus on the Chinese market. The report provides key statistics on the market status of the Azocarmine B manufacturers …
  • 除湿モルタルの世界市場2016
    The Global Dehumidifying Mortars Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Dehumidifying Mortars industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain …
  • 眼鏡フレーム及び取付け市場(~2018):ロシア(市場規模、動向、予測)
    This industry report offers the most up-to-date market data on the actual market situation, trends and future outlook for spectacle frames and mountings in Russia. The research includes historic market data from 2007 to 2013 and forecasts until 2018 which makes the report an invaluable resource for …
  • (株)ウヤン冷凍食品(wooyang frozen foods:製造業)の企業概要・財務データ:韓国企業調査
    韓国企業の概要及び財務データをまとめたレポートです。該当企業の設立日、住所、社員数、資本金、事業分野、連絡先、企業格付などの概要と、最近3年間の会計年度別貸借対照表(B/S)、損益計算書(P/L)、キャッシュ・フロー計算書(C/F)など財務データを調査しました。 韓国企業と取引する時、韓国に進出を検討する時、或いは韓国の競合企業を調べる時に、本データをご活用ください。追加のデータや詳しい情報が必要な場合は別途カスタムリサーチ(委託調査)サービスで対応致します。
  • サリチル酸ナトリウムの世界市場2016
    Notes:Production, means the output of Sodium Salicylate Revenue, means the sales value of Sodium Salicylate This report studies Sodium Salicylate in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacit …
  • 6軸溶接ロボットの世界及び中国市場 2018年
    The 'Global and Chinese Six Axis Welding Robots Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Six Axis Welding Robots industry with a focus on the Chinese market. The report provides key statistics on the market status of the Six …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DELVE41017115 )"セリアック病(Celiac Disease):治療薬開発パイプライン動向2014" (英文:Celiac Disease-Pipeline Insights, 2014)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。